These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2458182)

  • 1. The altered expression of MHC-class II determinants on monocytes of cancer patients.
    Uracz W; Stachura J; Pituch-Noworolska A; Popiela T; Czupryna A; Zembala M
    Cancer Immunol Immunother; 1988; 27(2):171-6. PubMed ID: 2458182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.
    Lehner T; Jones T
    Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
    Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
    J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human lymphocyte response in vitro by monocytes and their subsets.
    Zembala M; Pryjma J; Uracz W; Kowalczyk D; Ruggiero I; Mytar B
    Folia Biol (Praha); 1986; 32(1):1-11. PubMed ID: 2938988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan.
    Becker S
    J Immunol; 1984 Mar; 132(3):1249-54. PubMed ID: 6420462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.
    Burmester GR; Winchester RJ; Dimitriu-Bona A; Klein M; Steiner G; Sissons HA
    J Clin Invest; 1983 Jun; 71(6):1633-48. PubMed ID: 6575016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
    Degener T; Momburg F; Möller P
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma: infiltrating monocyte/macrophage subpopulations express functional mature phenotype.
    Neuchrist C; Grasl M; Scheiner O; Lassmann H; Ehrenberger K; Kraft D
    Br J Cancer; 1990 Nov; 62(5):748-53. PubMed ID: 2147109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; inhibition of Fc gamma-receptors by the covalently fixed C3 fragments.
    Erdei A; Bajtay Z; Fábry Z; Sim RB; Gergely J
    Mol Immunol; 1988 Mar; 25(3):295-303. PubMed ID: 2967429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of Ia molecules by human monocytes.
    Gonwa TA; Stobo JD
    J Clin Invest; 1984 Sep; 74(3):859-66. PubMed ID: 6432851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of major histocompatibility complex class Ia, Ib, and II molecules on monocytes-derived dendritic and macrophagic cells.
    Laupéze B; Fardel O; Onno M; Bertho N; Drénou B; Fauchet R; Amiot L
    Hum Immunol; 1999 Jul; 60(7):591-7. PubMed ID: 10426276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ia like (HLA-DR) antigens on human alveolar macrophages.
    Clerici N; Reboiras S; Fierro C; Leyva-Cobian F
    Clin Exp Immunol; 1984 Nov; 58(2):388-94. PubMed ID: 6209043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HLA class II antigens and secretion of interleukin-1 by monocytes and macrophages from adults and neonates.
    Glover DM; Brownstein D; Burchett S; Larsen A; Wilson CB
    Immunology; 1987 Jun; 61(2):195-201. PubMed ID: 3496273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-D sub-region products on human colorectal carcinoma.
    Ghosh AK; Moore M; Street AJ; Howat JM; Schofield PF
    Int J Cancer; 1986 Oct; 38(4):459-64. PubMed ID: 2428757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some fixation reagents reduce or abolish the detectability of Ia-antigen and HLA-DR on cells.
    Walker WS; Beelen RH; Buckley PJ; Melvin SL; Yen SE
    J Immunol Methods; 1984 Feb; 67(1):89-99. PubMed ID: 6421936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.